Palomino Laboratories Inc.
PALX
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.60M | 177.60K | 177.60K | 4.00K | 1.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.60M | 177.60K | 177.60K | 4.00K | 1.20K |
| Operating Income | -1.60M | -177.60K | -177.60K | -4.00K | -1.20K |
| Income Before Tax | -1.82M | -297.90K | -297.90K | -10.00K | -6.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.82M | -297.90K | -297.90K | -10.00K | -6.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.82M | -297.90K | -297.90K | -10.00K | -6.30K |
| EBIT | -1.60M | -177.60K | -177.60K | -4.00K | -1.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.54 | -0.09 | -0.09 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.34 | -0.06 | -0.06 | 0.00 | 0.00 |
| EPS Diluted | -0.54 | -0.10 | -0.10 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.34 | -0.06 | -0.06 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.38M | 3.21M | 3.21M | 3.98M | 1.66M |
| Average Diluted Shares Outstanding | 3.38M | 3.21M | 3.21M | 3.98M | 1.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |